Caxton Corporation’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Caxton Corporation’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-156,651	Closed	-$1.35M	–	15
2023 Q1	$1.35M	Buy	156,651 +429	+0.3%	+$3.54K	3.4%	6
2022 Q4	$1.35M	Buy	156,222 +15,359	+11%	+$124K	3.44%	7
2022 Q3	$845K	Sell	140,863 -53,714	-28%	-$292K	1.59%	12
2022 Q2	$1.05M	Buy	+194,577	New	+$1.05M	1.41%	10

Other funds holding VECT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caxton Corporation's VECT Position: Q2 2023 in Review

Caxton Corporation sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 156,651 shares — an estimated $1.35M sold.

Caxton Corporation first reported a position in VECT in Q2 2022 and held it in 4 quarters. The position peaked at $1.35M in Q4 2022. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

Caxton Corporation reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Caxton Corporation sold 156,651 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $1.35M.
Caxton Corporation first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2022 and held it in 4 quarters.
Caxton Corporation's VectivBio Holding AG Ordinary Shares position peaked at $1.35M in Q4 2022.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Caxton Corporation's 13F filing for Q2 2023, filed 14 Aug 2023.